Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sarepta Pursues DMD Gene Therapy Accelerated Approval To Be First To Market
New Data Analyses Swayed US FDA To Allow Early Filing
Jul 29 2022
•
By
Mandy Jackson
Sarepta hopes to fast-track SRP-9001 to DMD patients • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Gene Therapies
More from Advanced Therapies